These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 39109990
1. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid. Frank J, Son D, Szafranski K, Poon Y. J Manag Care Spec Pharm; 2024 Sep; 30(9):917-928. PubMed ID: 39109990 [Abstract] [Full Text] [Related]
3. Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin. Kim JY, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ, Jin SM, Kim JH. J Med Econ; 2024 Sep; 27(1):1245-1252. PubMed ID: 39275990 [Abstract] [Full Text] [Related]
4. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France. Alshannaq H, Pollock RF, Joubert M, Ahmed W, Norman GJ, Lynch PM, Roze S. J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332 [Abstract] [Full Text] [Related]
6. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective. Chaugule S, Graham C. J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578 [Abstract] [Full Text] [Related]
10. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US. Tunis SL, Minshall ME. Curr Med Res Opin; 2010 Jan 21; 26(1):151-62. PubMed ID: 19919376 [Abstract] [Full Text] [Related]
17. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. Rubin RR, Peyrot M. J Diabetes Sci Technol; 2009 Nov 01; 3(6):1402-10. PubMed ID: 20144395 [Abstract] [Full Text] [Related]
18. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Ann Intern Med; 2012 Sep 04; 157(5):336-47. PubMed ID: 22777524 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland. Brändle M, Azoulay M, Greiner RA. Int J Clin Pharmacol Ther; 2011 Mar 04; 49(3):217-30. PubMed ID: 21329624 [Abstract] [Full Text] [Related]
20. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System Compared to Standard Management of Type 1 Diabetes in a Singapore Setting. Gardner D, Lakkad M, Qiu Z, Inoue Y, Rama Chandran S, Wherry K. Diabetes Technol Ther; 2024 May 04; 26(5):324-334. PubMed ID: 38215206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]